Joincare Pharmaceutical Group Industry Co., Ltd.
600380.SSJoincare Pharmaceutical Group Industry Co., Ltd. in brief
Joincare Pharmaceutical Group Industry Co., Ltd. is a listed company in the Pharmaceutical industry, based in China. Its last known market value was $3.1 B (March 2026); there is no current figure. In the year to Dec 2021 it had sales of $2.3 B and a net profit of $193 M, about 8 cents of profit for every dollar of sales. It employs about 13,000 people. Its shares trade under the symbol 600380.SS (Shanghai).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Joincare Pharmaceutical Group Industry Co., Ltd.
Joincare Pharmaceutical Group Industry is an integrative business of Joincare includes invention, manufacture, selling and service of healthcare product company focus on building technology platforms such as monoclonal antibody, inhaled preparation, long term sustained release microspheres and nano lipid micro emulsion etc. The company annual revenue is 2.05 billion USD and 13,000 employee as on 2020. The headquarters is in China.
Market cap history
World rank over time
Rank in China: #708 (Jan 2020) · #629 (Jan 2021) · #769 (Jan 2022) · #771 (Dec 2022) · #687 (Jul 2023) · #669 (Jan 2024) · #923 (Mar 2026)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 8.3%
- Operating margin
- —
- Return on equity
- 6.6%
- Liabilities / assets
- 35.1%
- Revenue per employee
- $178 K
- Profit per employee
- $15 K
Annual results
- Revenue
- $2.3 B
- Operating income
- —
- Net income
- $193 M
Dec-2021 ending year
Balance sheet
- Total assets
- $4.5 B
- Total liabilities
- $1.6 B
- Total equity
- $2.9 B
Dec-2021 ending year
Mutual funds holding Joincare Pharmaceutical Group Industry Co., Ltd.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Vanguard Total International Stock Index FundThe Vanguard Group, Inc. | 1.87 M | $3 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Emerging Markets Stock Index FundThe Vanguard Group, Inc. | 1.68 M | $3 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇸🇪 Handelsbanken Global Index CriteriaHandelsbanken Fonder AB | 688,720 | $1 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Vanguard Ftse All-World Ex-Us Index FundThe Vanguard Group, Inc. | 339,200 | $1 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Dimensional Emerging Markets Value FundDimensional Fund Advisors LP | 219,500 | $0 M | — | <0.01% | −24% | Jul 31, 2026 |
| 🇺🇸 Schwab Emerging Markets Equity ETFCharles Schwab Investment Management, Inc. | 175,700 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 JPMorgan Diversified Return Emerging Markets Equity ETFJ.P. Morgan Investment Management Inc. | 168,000 | $0 M | — | 0.07% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P China ETFSSGA Funds Management, Inc. | 96,504 | $0 M | — | 0.03% | −4.0% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc. | 48,000 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Asia Pacific ETFSSGA Funds Management, Inc. | 27,600 | $0 M | — | <0.01% | +7.8% | Jun 30, 2026 |
| 🇺🇸 Emerging Markets Targeted Value PortfolioDimensional Fund Advisors LP | 24,700 | $0 M | — | 0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Esg International Stock ETFThe Vanguard Group, Inc. | 18,700 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 SA Emerging Markets Value FundFocus Advisor Solutions, LLC | 18,700 | $0 M | — | 0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Franklin FTSE China ETFFranklin Advisory Services, LLC | 18,300 | $0 M | — | 0.01% | −1.6% | Jun 30, 2026 |
| 🇺🇸 Dimensional World ex U.S. Sustainability Targeted Value PortfolioDimensional Fund Advisors LP | 7,100 | $0 M | — | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs MarketBeta Total International Equity ETFGoldman Sachs Asset Management, L.P. | 1,787 | $0 M | — | <0.01% | no change | May 29, 2026 |
| 🇺🇸 Goldman Sachs MarketBeta Emerging Markets Equity ETFGoldman Sachs Asset Management, L.P. | 1,040 | $0 M | — | <0.01% | −2.4% | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 17 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Where Joincare Pharmaceutical Group Industry Co., Ltd. operates: 1 country#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Only the headquarters country is on file for Joincare Pharmaceutical Group Industry Co., Ltd.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.
| Country | Presence | Revenue there |
|---|---|---|
| 🇨🇳 China | Headquarters | — |
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
How Joincare Pharmaceutical Group Industry Co., Ltd. compares in Pharmaceutical
- Revenue$2.3 B · higher than 79% of 324
- Net margin8.3% · higher than 50% of 313
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Joincare Pharmaceutical Group Industry Co., Ltd.🇨🇳 | $3.1 B | — | 8.3% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Mar 8, 2026 (last known)
- Annual results:
- Dec-2021 ending year
- Balance sheet:
- Dec-2021 ending year
- Employees:
- As on 2019
- Profile updated:
- Nov 4, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Joincare Pharmaceutical Group Industry Co., Ltd.? Verify and update this profile — free
Show Joincare Pharmaceutical Group Industry Co., Ltd.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.